胰十二指肠切除术联合纵向胰空肠吻合术治疗慢性胰腺炎伴可疑胰头肿块:开腹、腹腔镜与机器人入路的初步经验
本研究回顾性分析20例慢性胰腺炎伴可疑胰头肿块患者接受胰十二指肠切除术联合纵向胰空肠吻合术(PD-L)的临床结局。患者均为男性,平均年龄52.3±10.1岁,采用开腹(15例)、腹腔镜(3例)和机器人辅助(2例)入路。术后2例出现并发症,无胰瘘发生;中位随访14.5个月,78.9%(15/19)实现持续疼痛缓解且无需镇痛药。结论认为PD-L对特定慢性胰腺炎患者安全有效。
要点
- PD-L适用于慢性胰腺炎伴胰头占位可疑恶性及远端胰管结石性扩张的选定患者
- 20例中无胰瘘发生,术后并发症2例(腹腔出血、胃排空延迟各1例)
- 中位随访14.5个月,78.9%(15/19)获得持续疼痛缓解且无需镇痛药
核心结论
- PD-L是选定慢性胰腺炎伴胰头占位可疑恶性及远端胰管结石性扩张患者的安全有效手术选择。
主要发现
- 队列为20例男性患者,平均年龄52.3±10.1岁(范围32-70),开腹15例、腹腔镜3例、机器人辅助2例。
- 平均手术时间387.7±75.1分钟,平均术中出血量286±141.0 mL,平均总住院时间18.9±4.6天。
- 术后并发症2例:1例腹腔出血需血管造影栓塞,1例胃排空延迟经内镜引流处理;无胰瘘发生。
- 病理示慢性胰腺炎9例、PanIN 9例(PanIN-1 6例、PanIN-2 3例)、胰腺癌2例。
- 中位随访14.5个月,78.9%(15/19)实现持续疼痛缓解且无需镇痛药;6例BMI改善,5例血糖调控改善。
关键数值与推荐
- 术前慢性胰腺炎组(n=9)与PanIN/恶性组(n=11)比较无显著差异,吸烟指数组间差异未达统计学显著性(p=0.081)。
临床怎么用
- 对慢性胰腺炎伴胰头占位可疑恶性且远端胰管结石性扩张的选定患者,可考虑PD-L以兼顾疼痛缓解、功能保留与肿瘤监测。
局限性
- 回顾性单中心小样本研究,仅纳入男性患者,随访时间有限,需更大样本及更长随访验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: This study aims to evaluate the clinical outcomes of pancreaticoduodenectomy combined with longitudinal pancreatojejunostomy (PD-L) for chronic pancreatitis with a suspicious pancreatic head mass. We evaluated these derived surgical procedures with a focus on pain relief, functional preservation, and oncologic vigilance. METHODS: This retrospective single-center cohort study analyzed clinical data from 20 consecutive patients diagnosed with chronic pancreatitis who underwent PD-L at the Hepatobiliary Surgery Department of the First Affiliated Hospital of Xi'an Jiaotong University between December 2021 and December 2024. We systematically analyzed perioperative parameters, morbidity profiles, and histopathological characteristics. Post-discharge monitoring focused on quantitative pain assessment, pancreatic exocrine and endocrine functional status, and surveillance. RESULTS: The patients' cohort comprised 20 male patients (mean age 52.3 ± 10.1 years, range 32-70) who underwent PD-L procedures: open (n = 15), laparoscopic (n = 3), and robotic-assisted (n = 2) approaches. The mean operative time was (387.7 ± 75.1) minutes, with an average intraoperative blood loss of (286 ± 141.0) mL. The mean total length of hospital stay was (18.9 ± 4.6) days. Postoperative complications occurred in 2 patients: one case of abdominal hemorrhage requiring angiographic embolization and one case of delayed gastric emptying managed through endoscopic drainage. Notably, no pancreatic fistula were observed in any case. Pathology revealed chronic pancreatitis in 9 patients, PanIN in 9 (6 PanIN-1, 3 PanIN-2), and pancreatic cancer in 2. Preoperative comparisons between the CP group (n = 9) and the PanIN/malignant group (n = 11) showed no significant differences. Although considerable differences in the smoking index were observed between the two groups, they did not reach statistical significance (p = 0.081). During a median follow-up of 14.5 months, 78.9% (15/19) achieved sustained pain relief without the need for analgesics. Improvements in BMI and enhancements in glycemic regulation were observed in 6 and 5 patients, respectively. CONCLUSION: PD-L is a safe and effective surgical option for selected CP patients those with a space-occupying lesion in the pancreatic head that may raise suspicion of malignancy, concurrent with calculi-associated dilatation of the main pancreatic duct in the distal pancreatic body and tail segments.
引用
- Yang X, Wu S, Duan W, et al. Pancreaticoduodenectomy with longitudinal pancreatojejunostomy for chronic pancreatitis with suspicious pancreatic head mass: our initial experience with open, laparoscopic, and robotic approaches. Surg Endosc. 2026. PMID: 41489749. doi:10.1007/s00464-025-12433-6
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。